INTRODUÇÃO: Aproximadamente 170 milhões de pessoas são portadores de hepatite C crônica, sendo esta atualmente a principal causa de transplantes hepáticos no mundo. Os pacientes com hepatite crônica C são atualmente tratados com interferon e ribavirina (IFN/RBV). Estudos de associação do genoma associaram à resposta ao tratamento com IFN/RBV a um polimorfismo de nucleotídeo único (SNP) nas proximidades do gene da Interleucina 28B, que codifica a interferona-?. OBJETIVOS: Padronizar nova metodologia de baixo custo e menor tempo de execução para a genotipagem do polimorfismo rs12979860. Investigar a frequência do polimorfismo rs12979860, em uma coorte de pacientes com hepatite crônica C e sua associação com a resposta ao tratamento no Hospital das Clínicas da Universidade de São Paulo. MÉTODOS: A genotipagem foi realizada, por novo método diagnóstico, PCR multiplex CTPP (confronto de dois pares de iniciadores) e validado através de sequenciamento direto e PCR em tempo real. Um estudo retrospectivo foi realizado em 248 portadores de hepatite C crônica, tratados com interferon e ribavirina; 138 portadores de hepatite C crônica, virgens de tratamento e 240 doadores de sangue. Foi analisado o DNA, dados clínicos e demográficos, juntamente com dados sobre a resposta ao tratamento. RESULTADOS: O método de PCR CTPP foi padronizado e mostrou-se mais rápido e de menor custo comparado ao sequenciamento e PCR em tempo real. Pacientes com resposta virológica sustentada (RVS) apresentaram uma frequência de 33/61 (54,1%) para o genótipo C/C, de 21/61 (34,4%) para o genótipo C/T e 7/61 (11,5%) para o genótipo T/T. Pacientes que não tiveram RVS (Não RVS) apresentam uma frequência de 44/185 (23,8%) para o genótipo C/C, de 102/185 (55,1%) para o genótipo C/T e de 39/185 (21,1%) para o genótipo T/T. Os Não RVS estão associados ao genótipo C/T (p=0,002) e ao genótipo T/T (p=0,001) quanto comparados com o grupo de RVS. CONCLUSÕES: Esta dissertação descreve um método inovador, rápido e de baixo custo, o PCR CTPP, que detecta o polimorfismo rs12979860. O ensaio é internamente controlado e não requer a utilização de endonucleases de restrição ou equipamento especial. O polimorfismo rs12979860 é um preditor significativo da resposta ao tratamento com IFN/RBV em pacientes com infecção crônica pelo vírus da hepatite C. A genotipagem deste, em conjunto com os indicadores já existentes, pode identificar prováveis não respondedores ao tratamento / INTRODUCTION: Approximately 170 million people are chronic carriers of hepatitis C virus (HCV). Chronic HCV patients are currently treated with pegylated interferon and ribavirin (PEG- IFN/RBV). A genome-wide association with PEG-IFN/RBV treatment response and a single nucleotide polymorphism (rs12979860) has been identified near the interleukin 28B gene that encodes interferon-?-3. AIM: Describe an innovative, fast, and low-cost multiplex polymerase chain reaction with confronting two-pair primers that detects the rs12979860 polymorphism. Investigate the frequency of polymorphism rs12979860, among patients with chronic hepatitis C and association with to response treatment at the Hospital das Clínicas da Universidade de São Paulo. METHODS: Genotyping was performed by new diagnostic method, multiplex PCR CTPP (confronting two-pairprimers) and validated by direct sequencing and real time PCR. Retrospective study was conductedin 248 patients with hepatitis C chronic treated with interferon and ribavirin, 138 patients with chronic hepatitis C treatment-naïve and 240 blood donors. We analyzed DNA, clinical and demographic data, along with data onthe response to treatment. RESULTS AND CONCLUSIONS: The CTPP method was standardized and proved faster and lower cost compared to sequencing andreal time PCR. Patients with sustained virologic response (SVR) showed a frequency of 33/61 (54.1%) for the genotype C/C of 21/61 (34.4%) for the genotype C/T and 7/61 (11.5%) for genotype T/T. Patients with out sustained virologic response (Non SVR) have a frequency of 44/185 (23.8%) for the genotype C/C,102/185 (55.1%) for the genotype C/T and 39/185 (21.1%) for genotype T/T.The Non SVR are associated with genotype C/T (p = 0.002) and T/T genotype (p= 0.001) as compared with the group of SVR. Today, the IL28B genotyping is recomended by in the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver guidelines. As a result, physicians should consider testing IL28B in patients with hepatitis C; however, the implementation of routine genotyping has been halted in tertiary care hospitals because of the need for molecular biology tools that are expensive and highly complex. The CTPP multiplex assay described here detects in a single reaction the genotypes C/C, C/T, and T/T. This method allows rapid genotyping of the polymorphism rs12979860, which is reproducible in minimally equipped laboratories; it does not require any special equipment and is a relatively low-cost procedure. The PCR-CTPP method can be used for large testing arrays and is also suitable for genotyping a small number of samples

Introdução: estudos com Enfuvirtida (ENF) mostraram que mutações na HR1 da gp41 levam à resistência primária de cepas em pacientes sem tratamento prévio com inibidores de fusão (Derdeyn et al., 2000; Rimsky et. al., 1998; Sista et. al., 2002). Outros, que o uso contínuo de HAART leva à falha virológica (Shafer et. al., 1998; Shafer & Vuitton, 1999). Para a melhor escolha terapêutica recomenda-se usar a Genotipagem do HIV1 (Ministério da Saúde, 2008b; Perez-Elias et. al., 2003; Shafer et. al., 2001). Objetivos: avaliar o perfil de resistência do HIV1 ao ENF pelo sequenciamento da HR1 da gp41 em pacientes sob HAART, sem uso de inibidor de fusão. Realizar fenotipagem virtual da pol do HIV1 em trinta e duas cepas com resistência aos NRTI, NtRTI , NNRTI e PI para verificar indicação do ENF. Métodos: investigamos 877 prontuários de pacientes do CRT-DST/AIDS entre 5/2002 a 7/2005 e verificamos que 92 que haviam realizado o Teste de Genotipagem do HIV1 em nosso laboratório, sem tratamento prévio com inibidores de entrada poderiam participar do nosso estudo. O primeiro grupo, com 60 pacientes apresentou cepas sensíveis à pelo menos um antirretroviral (ARV) e o segundo com 32 cujas cepas apresentaram resistência parcial e completa às drogas. A região HR1/HR2 da gp41 foi seqüenciada com o kit Big Dye Terminator vs. 3.1. Alinhamos as seqüências e as comparamos com HXB2 através do programa BioEdit vs.7.0.9.0. As mutações de resistência ao ENF foram determinadas pelo algoritmo Francês (ANRS) e pelo da Universidade de Stanford. Submetemos as sequências ao Virtual Phenotype Assay (Virco, Bélgica) para obtermos a Fenotipagem Virtual. Os subtipos da HR1/HR2 da gp41 e do pol foram determinados por análises filogenéticas e os recombinantes, pelo Simplot v 3.5.1. Resultados: 89(97%) amostras foram seqüenciadas, 2 (2%) não amplificaram e 1 (1%) não tinha material suficiente. Destas, 82 (92%) eram do subtipo B, 6(7%) do F1 e 1(1%), do BF na gp41. No pol, 80(87%) eram B, 4(4%) eram F e 7(8%), eram FB. Três (3%) apresentaram resistência primária ao ENF, determinada pela N42D (1%), N43H (1%) e L44M (1%). Dez amostras tinham os polimorfismos Q39R(10%), N42H(10%), N42R(10%), N42N/S(10%) e N42S(60%). Na HR2, as mutações N126N/K, N126K/Q/E, E137E/K, E137K e S138S/A estavam presentes em 26% das cepas. Apesar das cepas apresentarem resistência aos ARV pelo teste de genotipagem, a fenotipagem virtual mostrou que 10% dos ARV ainda atuavam sobre elas, enquanto que 75% delas apresentaram resistência parcial e 15%, completa às drogas. Conclusão: nosso estudo sugere a introdução do teste de genotipagem da HR1/HR2 da gp41 antes de indicar do ENF em pacientes com falha terapêutica e que a Fenotipagem Virtual pode ser usada para a escolha do melhor esquema antirretroviral que permita uma supressão viral sustentada. / Background: studies using Enfuvirtide (ENF) have showed that mutations in the HR1 (gp41) have been associated with primary resistance in strains of the patients without previous treatment with fusion inhibitors. (Rimsky et. al.,1998; Derdeyn et al.,2000, Sista et. al.,2002). The widespread use of HAART may achieve maximal suppression of the viral load, but the viral rebound may occur, leading to virologic failure (Shafer et. al.,1998; Shafer & Vuitton,1999). To optimize therapeutic choices it is recommended to use the HIV1 Genotypic Assay. Objective: to evaluate the resistance profile in the HR1 in patients submitted to HAART, but naïve entry inhibitors. To make the Virtual Phenotypic Assay in the pol of the HIV1 strains isolated of the 32 patients with resistance to the antiretroviral (ARV) and to verify the possibility of using the ENF. Methods: we investigated 877 handbook patients of the CRT-DST/AIDS from May/2002 to July/2005. We identified 92 naïve patients to entry inhibitors included in our cohort to do genotypic assay; they were included in our research. The first group was composed by 60 persons with sensible strains to only one ARV. The second, with 32 presented strains with resistance to all ARV. HR1/HR2 was sequenced (ABIPrism BigDye Terminator vs 3.1). Bioedit Software vs.7.0.9.0 was used to compare sequences with the HIVHXB2. The resistance mutations to ENF were analyzed using French ANRS and Stanford HIV Drug Resistance Algorithm. The results by Virtual Phenotype Assay of 32 patients that presented regimen failure by Genotypic Assay predicted HIV phenotypic resistance. Subtype analysis were did by Phylogeny and the recombinants strains results, confirmed by Simplot v.3.5.1. Results: 89(97%) out of 92 samples were sequenced. Two of them (2%) could not be amplified and one (1%) we did not have enough material to use. In the HR1/HR2 82(92%) of the samples were typed as B, 6(7%), as F and 1(1%) as FB. In the pol 80(87%) were classified as B, 4(4%), as F and 7(8%) as FB. According to algorithms used, 3(3%) out of 89 ENF naïve patients presented complete resistance to this drug. One virus harbored the N42D mutation (1%), another, the N43H(1%) and the other one the L44M(1%). In 10 samples we observed the polymorphisms Q39R(1%), N42H(1%), N42R(1%), N42N/S(1%) and N42S(7%). In the HR2 domain the substitutions N126N/K, N126K/Q/E, E137E/K, E137K and S138S/A were present in 26% of the samples. Although strains presented resistance to the ARV by Genotypic Assay, in the Virtual Phenotypic Assay we verified that 10% of the drugs had some effect upon them. 75% of the strains presented partial and 15% completed resistance to ARV. Conclusion: it is important to introduce the HR1/HR2 genotyping test to verify resistance mutations to ENF before indicating this drug to patients with virologic failure. The virtual phenotypic assay can be used to select the better combination therapy to obtain viral suppression sustained response.

Les espèces bactériennes exhibent plusieurs états de structure de populations pouvant varier de clonale à panmictique selon l'importance des transferts horizontaux et la nature de leur écosystème. Dans mon travail de thèse, je me suis intéressé à trois espèces bactériennes, Staphylococcus aureus, Legionella pneumophila et Pseudomonas aeruginosa qui reflètent trois situations différentes. Afin de pouvoir décrire de façon rapide de grandes collections de souches, j'ai utilisé comme marqueurs de diversité le polymorphisme de séquences répétées en tandem appelées VNTRs, pour Variable Number Tandem Repeat. La méthode MLVA, ou Multiple Loci VNTR Analysis, est une méthode de typage moléculaire qui s’appuie sur l’étude concomitante du polymorphisme de plusieurs loci VNTRs. Dans un premier temps, j'ai conçu des protocoles de typage automatisés pour les trois espèces considérées, puis j'ai appliqué ces outils pour traiter de questions d'épidémiologie. S. aureus, espèce à structure clonale, est un pathogène majeur responsable notamment de toxi-infections alimentaires collectives (TIAC). Les travaux réalisés ont permis de démontrer la spécificité d’hôte de certains complexes clonaux et l’origine humaine des cas de TIAC. L. pneumophila est un pathogène de l’environnement dont la structure de population est atypique : présumée panmictique dans la nature, la bactérie semble connaitre une évolution clonale lorsque son écosystème est restreint, dans un milieu anthropique par exemple. L’étude épidémiologique menée sur la population de L. pneumophila dans la ville de Rennes a mis en évidence la présence d’un écotype, non impliqué dans les cas cliniques épidémiques, particulièrement adapté aux réseaux d’eau. P. aeruginosa, modèle de bactérie panmictique, colonise les bronches de patients atteints de mucoviscidose. Le suivi longitudinal de patients indique que les souches installées sont persistantes et quasi-exclusive de la niche qu’elles occupent. L’exploration de cette diversité du monde bactérien est un préalable à l’investigation épidémiologique des maladies infectieuses. Avec un même outil moléculaire de première intention, cette thèse retrace l’épidémiologie et la structure de trois espèces bactériennes très différentes. L’adaptation à un nouvel environnement (hôte animal, niche écologique, organe) est l'occasion d'expansions clonales. / Bacterial species exhibit diversity in their population structure varying from clonal to panmictic according to the abundance of horizontal transfer and the nature of their ecosystem. During my PhD, I focused on three bacterial species, Staphylococcus aureus, Pseudomonas aeruginosa and Legionella pneumophila, which reflect three different situations. To perform the characterisation of large strain collections, I studied the polymorphism of molecular markers called VNTRs for Variable Number Tandem Repeat. MLVA (Multiple Loci VNTR Analysis) is a PCR based typing method that relies on the concomitant analysis of several VNTRs loci. Initially, I designed automated typing protocols for the three species, then I applied these tools to address issues of epidemiology. S. aureus, a clonal species, is a major cause of food poisoning. The present work confirmed the existence of host-specific clonal complexes and demonstrated the predominantly human origin of foodborne disease cases. L. pneumophila is an environmental pathogen whose population structure is atypical: it is presumed panmictic in the environment but the bacterium expands clonally when the ecosystem is restricted, in an anthropogenic habitat for instance. A long-term epidemiological monitoring of L. pneumophila populations in the city of Rennes highlighted the presence of an ecotype, not involved in epidemic cases, particularly adapted to hot water supply systems. P. aeruginosa, a well-described panmictic bacterium, colonizes CF patients’ airways. The longitudinal monitoring of patients provided evidence that the settled strains were persistent and exhibited strong exclusivity for the occupied niche. Exploring the bacterial world diversity is a prerequisite for epidemiological investigation of infectious diseases. Using a first-line molecular tool, these works trace the epidemiology and the population structure of three bacterial species. The adaptation to a new environment (animal host, ecological niche, organ) generally results in clonal expansions.

Over the past several decades and increasingly in recent years, blood transfusions in the United States have plummeted as surgery has gotten more precise and less invasive. Alongside this decrease in general transfusions has been an increase in specific blood products for patients whose immune systems require special treatment. Simultaneously, trends in healthcare in the United States have incentivized regional hospitals to join large conglomerates. These coexisting factors have left regional blood banks, traditionally economically viable, in much weakened states. This thesis was born out of an initial curiosity to discover whether or not genetic science, and genotyping in particular, could benefit small regional blood banks by allowing them to bring down their costs of pre-transfusion blood testing or offer new products. I focus on the San Diego Blood Bank (SDBB) as a case study of the larger blood banking industry. In the course of this research, economic factors were taken into consideration as well as social and health. A minor question that was also discussed was whether genotyping not only help regional blood banks survive fiscally but also open the gateway to better patient outcomes and lower costs nationally of blood transfusions and their associated costs. Feasibility analyses and financial modeling suggest support for genotyping blood donors and transfusion recipients in order to more perfectly match blood transfusions through extended antigen matching.

Les travaux présentés dans cette thèse font suite à celle de Melle LE GOFF. Ils se concentrent sur la technologie HIFI brevetée et développée pendant ses travaux. Une première partie du travail présenté dans ce manuscrit concerne le test HIFI Blood 96™ et plus particulièrement les améliorations et les évolutions apportées au test afin d'en faire un véritable outil de génotypage, multiparamétrique et haut-débit pouvant être installé dans les banques de sang dans le but de constituer des inventaires de sang génotypé de façon étendue, participant ainsi à améliorer la sécurité transfusionnelle. Il permet de caractériser 96 échantillons sur 15 polymorphismes (divisés en deux panels) associés aux groupes sanguins en approximativement 4h30. Cette plateforme a fait l'objet d'une étude de validation à moyenne échelle sur 583 donneurs pour le panel 1 et 190 donneurs pour le panel 2. La deuxième partie des travaux décrit l'adaptation de la technologie HIFI appliquée au diagnostic des pathologies respiratoires, avec le développement d'une autre plateforme, ReSynPlex, en partenariat avec 3 équipes de recherche de Grenoble / The work reported in this thesis follows the one undertaken by Ms LE GOFF. It is focused on HIFI technology, which is patented and developed during her thesis. The first part of this work concerns the HIFI Blood 96™ test, and particularly the improvements and developments adduced to the test to make it a real diagnostic tool, multiparametric and high-throughput which can be implemented in blood banks in order to constitute negative antigen inventories, thus contributing to improve blood safety. It allows to characterize 96 samples on 15 polymorphisms (divided in two panels) associated to blood group systems in approximately 4.5 hours. A mesoscale validation study has been conducted on 583 samples for panel 1 and 190 samples for panel 2. The second part of this work describes the adaptation of HIFI technology applied to diagnosis of respiratory tract infections, with the development of another platform, ReSynPlex, in partnership with 3 research teams in Grenoble

<p>In many forensic cases, such as mass disasters reconstruction cases, the recovered DNA is highly degraded. In such incidences, typing of STR loci has become one of the most powerful tools for retrieving information from the degraded DNA. However, as DNA degradation proceeds, three phenomena occur consecutively: loci imbalance, allele dropout and no amplification. To solve the problem of degraded DNA, redesigned primer sets have been developed in which the primers were positioned as close as possible to the STR repeat region. These reduced primer sets were called Miniplexes. Unfortunately, a few of the CODIS STR loci cannot be made into smaller amplicons. For this reason non-CODIS miniSTRs have been developed. The present study was undertaken for the population genetic analysis of microsatellite variation in four South African populations / Afrikaner, Xhosa, Mixed Ancestry and Asian Indian using eight non-CODIS miniSTR loci. These miniSTRs loci were characterized within the populations by estimating the levels of diversity of the markers, estimating the population genetic parameters, and studying the inter-population relationships. All of the miniSTRs were amplified successfully and the genetic variability parameters across all loci in Afrikaner, Mixed Ancestry, Asian Indian and Xhosa were estimated to be in the range of 3 (D4S2364) to 12 (D9S2157) alleles, the total number of alleles over all loci ranged from 100 to 204, the allelic richness ranged from 3.612 to 10.307 and the heterozygosity ranged from 0.4360 to 0.8073. Genetic distance was least between Afrikaner and Asian Indian and highest between Xhosa and Mixed Ancestry. Deviations from Hardy-Weinberg equilibrium were not observed for most of the loci. The low mean FIS (-0.027) and FIT (-0.010) and FST (0.017) values across the populations indicated low level of inbreeding within (FIS) and among (FST) the populations. The Asian Indian population showed higher levels of the inbreeding coefficient, indicating less gene exchange between it and other populations. These 8 markers can be used for genetic investigations and assessing population structure. The study contributed to the knowledge and genetic characterization of four South African populations. In addition, these MiniSTRs prove to be useful in cases where more genetic information is needed.</p>

Advancements in the field of biotechnology are expanding the scientific horizon and a promising era is envisioned with personalized medicine for improved health. The amount of genetic data is growing at an ever-escalating pace due to the availability of novel technologies that allow massively parallel sequencing and whole-genome genotyping, that are supported by the advancements in computer science and information technologies. As the amount of information stored in databases throughout the world is growing and our knowledge deepens, genetic signatures with significant importance are discovered. The surface of such a set in the data mining process may include causative- or marker single nucleotide polymorphisms (SNPs), revealing predisposition to disease, or gene expression signatures, profiling a pathological state. When targeting a reduced set of signatures in a large number of samples for diagnostic- or fine-mapping purposes, efficient interrogation and scoring require appropriate preparations. These needs are met by miniaturized and parallelized platforms that allow a low sample and template consumption. This doctoral thesis describes an attempt to tackle some of these challenges by the design and implementation of a novel assay denoted Trinucleotide Threading (TnT). The method permits multiplex amplification of a medium size set of specific loci and was adapted to genotyping, gene expression profiling and digital allelotyping. Utilizing a reduced number of nucleotides permits specific amplification of targeted loci while preventing the generation of spurious amplification products. This method was applied to genotype 96 individuals for 75 SNPs. In addition, the accuracy of genotyping from minute amounts of genomic DNA was confirmed. This procedure was performed using a robotic workstation running custom-made scripts and a software tool was implemented to facilitate the assay design. Furthermore, a statistical model was derived from the molecular principles of the genotyping assay and an Expectation-Maximization algorithm was chosen to automatically call the generated genotypes. The TnT approach was also adapted to profiling signature gene sets for the Swedish Human Protein Atlas Program. Here 18 protein epitope signature tags (PrESTs) were targeted in eight different cell lines employed in the program and the results demonstrated high concordance rates with real-time PCR approaches. Finally, an assay for digital estimation of allele frequencies in large cohorts was set up by combining the TnT approach with a second-generation sequencing system. Allelotyping was performed by targeting 147 polymorphic loci in a genomic pool of 462 individuals. Subsequent interrogation was carried out on a state-of-the-art massively parallelized Pyrosequencing instrument. The experiment generated more than 200,000 reads and with bioinformatic support, clonally amplified fragments and the corresponding sequence reads were converted to a precise set of allele frequencies. / QC 20100813

No description available.

<p>In many forensic cases, such as mass disasters reconstruction cases, the recovered DNA is highly degraded. In such incidences, typing of STR loci has become one of the most powerful tools for retrieving information from the degraded DNA. However, as DNA degradation proceeds, three phenomena occur consecutively: loci imbalance, allele dropout and no amplification. To solve the problem of degraded DNA, redesigned primer sets have been developed in which the primers were positioned as close as possible to the STR repeat region. These reduced primer sets were called Miniplexes. Unfortunately, a few of the CODIS STR loci cannot be made into smaller amplicons. For this reason non-CODIS miniSTRs have been developed. The present study was undertaken for the population genetic analysis of microsatellite variation in four South African populations / Afrikaner, Xhosa, Mixed Ancestry and Asian Indian using eight non-CODIS miniSTR loci. These miniSTRs loci were characterized within the populations by estimating the levels of diversity of the markers, estimating the population genetic parameters, and studying the inter-population relationships. All of the miniSTRs were amplified successfully and the genetic variability parameters across all loci in Afrikaner, Mixed Ancestry, Asian Indian and Xhosa were estimated to be in the range of 3 (D4S2364) to 12 (D9S2157) alleles, the total number of alleles over all loci ranged from 100 to 204, the allelic richness ranged from 3.612 to 10.307 and the heterozygosity ranged from 0.4360 to 0.8073. Genetic distance was least between Afrikaner and Asian Indian and highest between Xhosa and Mixed Ancestry. Deviations from Hardy-Weinberg equilibrium were not observed for most of the loci. The low mean FIS (-0.027) and FIT (-0.010) and FST (0.017) values across the populations indicated low level of inbreeding within (FIS) and among (FST) the populations. The Asian Indian population showed higher levels of the inbreeding coefficient, indicating less gene exchange between it and other populations. These 8 markers can be used for genetic investigations and assessing population structure. The study contributed to the knowledge and genetic characterization of four South African populations. In addition, these MiniSTRs prove to be useful in cases where more genetic information is needed.</p>

This work is concerned with the genetic basis of normal human pigmentation variation. Specifically, the role of polymorphisms within the solute carrier family 45 member 2 (SLC45A2 or membrane associated transporter protein; MATP) gene were investigated with respect to variation in hair, skin and eye colour ― both between and within populations. SLC45A2 is an important regulator of melanin production and mutations in the gene underly the most recently identified form of oculocutaneous albinism. There is evidence to suggest that non-synonymous polymorphisms in SLC45A2 are associated with normal pigmentation variation between populations. Therefore, the underlying hypothesis of this thesis is that polymorphisms in SLC45A2 will alter the function or regulation of the protein, thereby altering the important role it plays in melanogenesis and providing a mechanism for normal pigmentation variation. In order to investigate the role that SLC45A2 polymorphisms play in human pigmentation variation, a DNA database was established which collected pigmentation phenotypic information and blood samples of more than 700 individuals. This database was used as the foundation for two association studies outlined in this thesis, the first of which involved genotyping two previously-described non-synonymous polymorphisms, p.Glu272Lys and p.Phe374Leu, in four different population groups. For both polymorphisms, allele frequencies were significantly different between population groups and the 272Lys and 374Leu alleles were strongly associated with black hair, brown eyes and olive skin colour in Caucasians. This was the first report to show that SLC45A2 polymorphisms were associated with normal human intra-population pigmentation variation. The second association study involved genotyping several SLC45A2 promoter polymorphisms to determine if they also played a role in pigmentation variation. Firstly, the transcription start site (TSS), and hence putative proximal promoter region, was identified using 5' RNA ligase mediated rapid amplification of cDNA ends (RLM-RACE). Two alternate TSSs were identified and the putative promoter region was screened for novel polymorphisms using denaturing high performance liquid chromatography (dHPLC). A novel duplication (c.–1176_–1174dupAAT) was identified along with other previously described single nucleotide polymorphisms (c.–1721C>G and c.–1169G>A). Strong linkage disequilibrium ensured that all three polymorphisms were associated with skin colour such that the –1721G, +dup and –1169A alleles were associated with olive skin in Caucasians. No linkage disequilibrium was observed between the promoter and coding region polymorphisms, suggesting independent effects. The association analyses were complemented with functional data, showing that the –1721G, +dup and –1169A alleles significantly decreased SLC45A2 transcriptional activity. Based on in silico bioinformatic analysis that showed these alleles remove a microphthalmia-associated transcription factor (MITF) binding site, and that MITF is a known regulator of SLC45A2 (Baxter and Pavan, 2002; Du and Fisher, 2002), it was postulated that SLC45A2 promoter polymorphisms could contribute to the regulation of pigmentation by altering MITF binding affinity. Further characterisation of the SLC45A2 promoter was carried out using luciferase reporter assays to determine the transcriptional activity of different regions of the promoter. Five constructs were designed of increasing length and their promoter activity evaluated. Constitutive promoter activity was observed within the first ~200 bp and promoter activity increased as the construct size increased. The functional impact of the –1721G, +dup and –1169A alleles, which removed a MITF consensus binding site, were assessed using electrophoretic mobility shift assays (EMSA) and expression analysis of genotyped melanoblast and melanocyte cell lines. EMSA results confirmed that the promoter polymorphisms affected DNA-protein binding. Interestingly, however, the protein/s involved were not MITF, or at least MITF was not the protein directly binding to the DNA. In an effort to more thoroughly characterise the functional consequences of SLC45A2 promoter polymorphisms, the mRNA expression levels of SLC45A2 and MITF were determined in melanocyte/melanoblast cell lines. Based on SLC45A2’s role in processing and trafficking TYRP1 from the trans-Golgi network to stage 2 melanosmes, the mRNA expression of TYRP1 was also investigated. Expression results suggested a coordinated expression of pigmentation genes. This thesis has substantially contributed to the field of pigmentation by showing that SLC45A2 polymorphisms not only show allele frequency differences between population groups, but also contribute to normal pigmentation variation within a Caucasian population. In addition, promoter polymorphisms have been shown to have functional consequences for SLC45A2 transcription and the expression of other pigmentation genes. Combined, the data presented in this work supports the notion that SLC45A2 is an important contributor to normal pigmentation variation and should be the target of further research to elucidate its role in determining pigmentation phenotypes. Understanding SLC45A2’s function may lead to the development of therapeutic interventions for oculocutaneous albinism and other disorders of pigmentation. It may also help in our understanding of skin cancer susceptibility and evolutionary adaptation to different UV environments, and contribute to the forensic application of pigmentation phenotype prediction.